TOPIGEN Pharmaceuticals

Related by string. * Topigen : TOPIGEN Pharmaceuticals Inc. . TOPIGEN / pharmaceuticals . PHARMACEUTICALS . PHARMACEUTICAL . pharma ceutical . pharmaceutical . Pharma ceutical : Barr Pharmaceuticals Inc. . Pharmaceutical Benefits Scheme . MAP Pharmaceuticals generates . Active Pharmaceutical Ingredients . MAP Pharmaceuticals . Ortho McNeil Janssen Pharmaceuticals * *

Related by context. Frequent words. (Click for all words.) 60 Closes Financing 59 Announces Initiation 59 Complete Merger 58 Secures Additional 57 Grants Options 57 DARA BioSciences 57 Announces Additions 57 Updates Shareholders 57 Completes Private Placement 57 Announces Definitive Agreement 57 IIROC Resume 57 Succession Plan 56 Announces Stockholder Approval 56 Accelerate Growth 56 Regado Biosciences 56 Exercises Option 56 Further Strengthens 56 Closes Private Placement 56 Previously Announced 56 Completes Merger 55 Genaera Corporation 55 Achieves Milestone 55 Stockholders Approve Merger 55 Enters Into Letter 55 Newly Created 55 Review Initiated 55 Renewable Energy Projects 54 Announces Private Placement 54 Restructures 54 Announces Non Brokered 54 PsychoGenics 54 Acquire Assets 54 Announces Termination 54 Files Shelf Registration Statement 54 Finalizes Acquisition 54 Rodinia Minerals Inc. 54 Shareholder Update 54 Equity Stake 54 Announce Completion 54 Multi Billion Dollar 53 Strategic Direction 53 Regains Compliance 53 Strengthens Its 53 PositiveID Corporation 53 Media Advisory REMINDER 53 Signs Joint Venture 53 Announces Organizational Changes 53 Announces Signing 53 Announces Intention 53 Announce Joint Venture 53 IIROC Halt 53 Acquires Majority 53 CardioComm Solutions Inc. 53 Secures Funding 53 Extends Tender Offer 53 Fibrocell Science Inc. 52 Profitable Growth 52 Exclusive License 52 Private Placement Offering 52 Shareholders Approve 52 Annouces 52 Announces Shareholder Approval 52 Spins Off 52 Client Roster 52 Announces Formation 52 Acrongenomics 52 Response Genetics 52 Commercialization Agreement 52 Licensing Agreements 51 Announce Merger 51 Files Annual Report 51 Omni Bio 51 Signs Definitive Agreement 51 Momentum Continues 51 Closes Acquisition Of 51 Subsidiary Signs 51 Altea Therapeutics 51 Report Analyzes 51 Shareholders Approve Merger 51 Licensing Deal 51 Strategic Relationship 51 Signs LOI 51 Majority Stake 51 Extends Reach 51 Diversifies 51 Million Financing 51 Announces Departure 51 Has Joined 51 bluebird bio 51 Increases Stake 51 Enters Into Agreement 51 Signs Agreements 51 Develop Next Generation 51 Announces Sponsorship 51 Announces Intent 51 Announces Successful Completion 51 Minority Stake 51 Acquires Exclusive 50 VioQuest Pharmaceuticals 50 GBP# Million 50 Capital Invests

Back to home page